United Therapeutics Corp (NASDAQ:UTHR)

During the Trading Day
165.78 -3.50 / -2.07%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
169.03 +3.25 / +1.96%
Volume: 8.5K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 2
Quarter 3
Quarter 4
Quarter 1
Revenue and IncomeNet Revenues322.8M330.0M346.4M327.5M
Cost of Goods Sold31.1M32.7M6.8M12.4M
Depreciation And Amortization7.6M8.1M8.9M8.3M
Operating ExpensesGross Income284.1M289.1M330.6M306.7M
General Expenses107.8M321.4M152.0M321.6M
Research And Development39.7M118.9M71.5M110.2M
Total Operating Expenses146.5M362.2M167.8M342.3M
Non-Operating ExpensesOperating Income176.3M-32.2M178.6M-14.8M
Extraordinary Credit1.1M0.000.000.00
Interest Expense On Debt4.7M4.7M3.5M2.1M
Other Expenses-800.0K1.1M-285.0K93.0K
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income173.0M-35.8M174.8M-16.8M
Income Taxes-61.2M-10.6M-58.8M-151.0K
Net Income111.9M-25.2M115.9M-16.6M
Shares To Calculate EPSShares To Calculate EPS47.6M47.3M47.4M46.7M
Shares To Calculate EPS Diluted53.3M47.3M53.5M46.7M
Earnings Per ShareEPS$2.10-$0.53$2.17-$0.36
EPS Diluted$2.10-$0.53$2.17-$0.36

To view my watchlist

Not a member yet?

Sign up now for a free account